How does Section 453 handle deferred gains from the sale of a startup with high growth potential but minimal current revenue?

Question

Tyler Smith · Accepted Answer

When a startup with significant intellectual property (IP) or market potential but limited immediate revenue is sold, Section 453 offers a vital mechanism for deferring capital gains tax. The challenge often lies in valuing the future growth potential, which can directly influence the sale price and, consequently, the installment payments.  For such sales, the *gross profit percentage* is crucial. This is calculated by dividing the gross profit (selling price minus the adjusted basis) by the contract price. Subsequent payments received are then allocated between return of basis and taxable gain based on this percentage.

Contingent payment sales are particularly relevant here. If the sale price depends on future performance metrics (e.g., earn-outs based on revenue milestones or user acquisition), Section 453 allows for the deferral of tax until those contingent payments are realized. The IRS generally requires sellers to estimate the maximum selling price and the period over which payments will be received, even if uncertain. If a maximum selling price cannot be determined, the basis is recovered ratably over a fixed period, or if the payment period is also indefinite, basis recovery rules can become more complex, often requiring the use of the income forecast method or other approved methods. This flexibility makes Section 453 a powerful tool for founders hoping to maximize their net proceeds from a high-potential, early-stage company sale.